Both the futures market and the bond market expect multiple rate hikes by the end of this year.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
(Bloomberg) -- Moonshot AI is poised to make its Kimi K3 model available for public download, expanding its reach and influence in the global open software community at a time of growing US concern about Chinese encroachment into the top echelons of AI development.Most Read from BloombergDeepSeek Suspends Fundraising After Viral US-China PostsSpaceX at $100 Would Imply Zero AI Value, Morgan Stanley SaysUS, Iran Extend Pause in Strikes as Oman Holds Hormuz TalksTrump Seethes as Iran War Spirals A
Alphabet just raised capital and reaffirms guidance again.
The fund never picked a single stock. That turned out to be the point.
Contrary to a common assumption, not every name in this sector is a stodgy slow-mover.
The most dangerous moment in a 30-year retirement is not the last decade but the first twelve months, and most new retirees walk straight into it without a plan. Three ETFs address three very different ways a year-one crash can permanently hollow out your portfolio.
Nvidia is in talks to provide a roughly $250 billion financing for OpenAI as part of a massive data center project, The Wall Street Journal reported on Sunday. The guarantees from Nvidia would help the ChatGPT maker lease a 10-gigawatt project that SoftBank's energy subsidiary is developing in southern Ohio, the newspaper said, citing people familiar with the matter. Nvidia, OpenAI and U.S. Commerce Department did not respond to requests for comment outside regular business hours.
GE Aerospace is performing very well as a business, and perhaps even better as a stock.
The world needs dependable energy, and the oil and gas services giant is helping its customers supply it.
A big bank just valued the rocket maker with a 2x Elon Musk premium baked in -- and still came up short of the IPO price.
Project would be one of the largest AI computing hubs and involve power controlled by the U.S. government.
Both stocks are cheaper than the S&P 500.
The telecom already has a plan for every dollar of its massive free cash flow stream -- and investors should love it.
Texas Instruments' analog chips act as the middlemen between the electric grid and AI chips.
Microsoft stock has struggled this year.
Quantum computing pure plays may tempt investors, but the better stock pick may be the megacap that's providing a bridge between quantum systems and classical supercomputers.
The airline just posted the biggest quarter in its history and told investors it may lose money this year. Both are true.
Mark Cuban has argued that humanoid robots face major limitations. While they may initially be popular for general household tasks, he believes application-specific robots will emerge as the ultimate winner. Cuban took to X on Thursday and stated that humanoid...
Apple has a headstart, but it's not stable.
South Korean President Lee Jae Myung flew to San Francisco on July 24 for a summit with the most powerful names in artificial intelligence. Jensen Huang was there. Sam Altman was there. The heads of Samsung, SK Group, Hyundai Motor and Naver flew in. By the end of the day, roughly $950 billion in ...
Private credit isn't even the main story at Blackstone.
The neocloud company's stock has plunged, but its business model hasn't suddenly broken.
The Schwab U.S. Dividend Equity ETF (SCHD) has become one of the industry's premier dividend ETFs.
Rising capital expenditures and tightening margins are not a good combination.
MercadoLibre's narrowing margins have grabbed investors' attention, but they may not tell the full story.
Plug Power shares have consistently struggled to hold onto their gains.
Far from "yield traps," these high-yield dividend stocks represent good value at current prices.
As one of the world's most disruptive businesses, this leading travel platform should be on every investor's radar.
The pharmaceutical company has a likely blockbuster drug as the flagship of its pipeline.
They're not the sort of names you brag about owning, but they'll certainly get the job done.